Navigation Links
MEDRAD Builds on Success of P3T Cardiac CT Injection Software
Date:11/24/2008

ters is a promising approach."

Pulmonary Embolism (PE) is a sudden blood clot or blockage in a lung artery and is a serious condition. At least 100,000 cases of PE occur each year in the United States, according to the National Institutes of Health. PE is the third most common cause of death in hospitalized patients, and if left untreated, kills about 30 percent of patients who have it. Most of those who die do so within the first few hours of the event. CT imaging is often used in the emergency department setting to quickly identify the presence of life-threatening disorders like PE, making efficiency important in quickly and accurately diagnosing the condition. CT has a high specificity and sensitivity in ruling out PE, and researchers in a 2005 meta-analysis (JAMA 2005; 293:2012-17) found that the negative predictive value of a CT angiography of the pulmonary arteries was 99.4%.

MEDRAD, Inc. is a worldwide leading provider of medical devices and services that enable and enhance imaging and therapeutic procedures of the human body. For diagnostic imaging, MEDRAD's product offerings include a comprehensive line of vascular injection systems, magnetic resonance (MR) surface coils and patient care products, and equipment services. The company also offers products used in vascular intervention. MEDRAD's total 2007 revenues were $525 million. In 2003, MEDRAD received the Malcolm Baldrige National Quality Award, the top honor a U.S. company can receive for quality and business excellence. The company's world headquarters is near Pittsburgh, Pennsylvania, in the United States. MEDRAD is an affiliate of Bayer AG. More company information is available at http://www.medrad.com.

The Bayer Group is a global enterprise with core competencies in the fields of healthcare, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is one of the w
'/>"/>

SOURCE MEDRAD, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. MEDRAD Announces eCoil(TM) for Siemens, Philips 3.0T MR Scanners
2. MEDRAD Plant Named IndustryWeek Magazine Award Finalist
3. MEDRAD Mobile MR Injector Meets Challenges of MR Trailers
4. MEDRAD(R) Revenues Grow 10 Percent in 2007
5. MEDRAD and PETNET Solutions Partner for Innovative FDG Delivery
6. MEDRAD Receives FDA 510(k) Clearance for Wireless MR Infusion System
7. MEDRAD Multi Vendor Service Forms Alliance with Wetsco
8. Fat Builds Up in Hearts Before Diabetes Onset
9. SYMX Builds on Top of New Microsoft Technologies to Offer Hospitals Real-Time Business and Patient Safety Solutions Using RFID Data
10. Telecommunications Technology Boosts Revenue Generation by Billions and Builds Positive Brand Experience
11. Biotechnology Builds a New Heart
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... Roughly four in 10 uninsured patients who have been ... not have the lung disease, a small new study ... on an evaluation of symptoms, rather than by means ... spirometry, which shows how well a patient,s lungs are ... exhale and how long that takes. The ...
(Date:5/22/2013)... May 22, 2013 Teams who focus ... improvements use the new Do-Done StepTracker whiteboard as a ... the Do-Done board to display the current status of ... production cells and departments is listed down the side ... start a project, the squares are filled with yellow ...
(Date:5/22/2013)... John Mathews from the University of Melbourne said this ... the undoubted benefits from CT scans in diagnosing and ... the British Medical Journal today and involved ... and the International Agency for Research on Cancer in ... were very useful in providing detailed three dimensional pictures ...
(Date:5/22/2013)... than 40 percent of patients being treated for ... have the disease, researchers found after evaluating the ... chronic obstructive pulmonary disease. , "While there have ... there has not been a U.S.-based study that ... Ghattas, MD., MSc, a second-year medical resident ...
(Date:5/22/2013)... The PreDiabetes Center of King of ... Philadelphia Tour de Cure, a premier cycling event that brings ... stopping the spread of diabetes , a chronic disease ... Tour de Cure will take place Saturday, June 1 at ... 30 minutes outside of Philadelphia, between the hours of 7:30 ...
Breaking Medicine News(10 mins):Health News:COPD May Be Over-Diagnosed Among Uninsured 2Health News:Project Managers Organize Manufacturing Projects and Training with the New Steptracker Project Status Magnetic Whiteboards 2Health News:Small increase in cancer risk following CT scans in childhood and adolescence 2Health News:Study finds COPD is over-diagnosed among uninsured patients 2Health News:Study finds COPD is over-diagnosed among uninsured patients 3Health News:PreDiabetes Centers to Appear at the Philadelphia Tour de Cure 2Health News:PreDiabetes Centers to Appear at the Philadelphia Tour de Cure 3
... EDITOR,S PICK: Possible new approach to treating a life-threatening ... is a life-threatening disease of the blood system. The ... of the protein von Willebrand factor, which promote the ... throughout the body. Current treatments are protracted and associated ...
... -- Breast-feeding may help reduce some long-term negative side ... cancer, according to a new study. The findings ... breast-feeding should be part of routine recommendations for a ... from St. Jude Children,s Research Hospital in Memphis, Tenn. ...
... during cardiovascular surgery, resulting in elevated circulating levels of ... microcirculation and gut wall integrity is unclear. A ... in the World Journal of Gastroenterology addresses ... plasma levels similar to those found during cardiovascular surgery. ...
... conducted at Sahlgrenska University Hospital in Gothenburg and at ... of 18 and 65. Half the group was randomly ... half to maintain their usual lifestyle. Both groups ... group increased their physical activity on their own, but ...
... Lake, N.Y. There is an ongoing battle in the ... -- a race between scientists working to develop a vaccine ... use plague as a weapon. "Governments remain concerned that ... could kill thousands," said Stephen Smiley, a leading plague researcher ...
... 25, 2011) -- A child,s taste preferences begin at home ... say, young kids learn quickly what brands deliver the goods. ... involving two separate experiments, researchers found that salt, sugar and ... children already could equate their taste preferences to brand-name fast-food ...
Cached Medicine News:Health News:JCI table of contents: Jan. 25, 2011 2Health News:JCI table of contents: Jan. 25, 2011 3Health News:JCI table of contents: Jan. 25, 2011 4Health News:JCI table of contents: Jan. 25, 2011 5Health News:JCI table of contents: Jan. 25, 2011 6Health News:JCI table of contents: Jan. 25, 2011 7Health News:JCI table of contents: Jan. 25, 2011 8Health News:Breast-Feeding May Counter Some Effects of Childhood Cancer 2Health News:New discovery could lead to vaccines for plague and bacterial pneumonias 2Health News:Preschool kids know what they like: Salt, sugar and fat 2Health News:Preschool kids know what they like: Salt, sugar and fat 3
(Date:5/22/2013)... WORCESTER, Mass. and TORONTO ... www.generex.com ) (OTCBB: GNBT) today announced three presentations demonstrating ... developed by its wholly-owned subsidiary, Antigen Express, Inc. ( ... annual meeting of the American Society of Clinical Oncology ... from May 31 through June 4, 2013. ...
(Date:5/22/2013)... , 22. Mai 2013  Grifols, ... in Barcelona , Spanien, ... dass eine höhere Dosis von PROLASTIN©-C (Alpha1-Proteinasehemmer ... mit Alpha1-Antitrypsinmangel (AAT) auf ein Niveau anhebt, ... bezeichneten Bereichs liegt. ATT-Mangel ist eine lebensbedrohliche, ...
(Date:5/22/2013)... TORONTO , May 22, 2013  Medifocus, Inc. ... John Mon , Chief Operating Officer, will present at ... 30, 2013 in New York City ... presentation is scheduled to begin at 4:00 p.m. EDT and ... webcast, go to:   http://wsw.com/webcast/marcum/mfs.v/   For more ...
Breaking Medicine Technology:Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 2Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 3Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 4Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 2Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 3Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 4Medifocus, Inc. to Present At The Second Annual Marcum LLP MicroCap Conference 2Medifocus, Inc. to Present At The Second Annual Marcum LLP MicroCap Conference 3
... Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced ... acquire Proteolix, Inc., a privately held biopharmaceutical company ... target the proteasome for the treatment of hematological ... carfilzomib, is a proteasome inhibitor currently in multiple ...
... , EXTON, Pa., Oct. 9 Kensey Nash ... release its earnings results for its first quarter ended September ... 22, 2009. , Joe Kaufmann, President and CEO, ... Thursday, October 22, 2009 at 9:00 A.M. Eastern Time. ...
Cached Medicine Technology:Onyx Pharmaceuticals to Acquire Proteolix, Inc. 2Onyx Pharmaceuticals to Acquire Proteolix, Inc. 3Onyx Pharmaceuticals to Acquire Proteolix, Inc. 4Onyx Pharmaceuticals to Acquire Proteolix, Inc. 5Kensey Nash Corporation Announces Its First Quarter Fiscal Year 2010 Earnings Release Date and Teleconference 2
... German Craftsmanship have produced the ... world. Ocutek now makes them ... of the coveted Meisterbrief certificate, ... are qualified to become Ocutek ...
... German Craftsmanship have produced the ... world. Ocutek now makes them ... of the coveted Meisterbrief certificate, ... are qualified to become Ocutek ...
... of German Craftsmanship have produced ... the world. Ocutek now makes ... holders of the coveted Meisterbrief ... apprenticeship, are qualified to become ...
... Centuries of German Craftsmanship ... instrumentation in the world. Ocutek ... you! Only holders of the ... and eight-year apprenticeship, are qualified ...
Medicine Products: